Table 3.

Generalized linear models predicting psychopathology at T1.

Response	Predictorsa	OR (95% confidence interval) p-value
BAI	PIL (T1)	0.67 (0.56, 0.81); p < 0.001***
	Personal and family/friends’ exposure to SARS-CoV-2 (T1)	8.01 (2.17, 29.53); p = 0.002**
BDI-II	PIL (T1)	0.67 (0.57, 0.79); p < 0.001***
	Personal and family/friends’ exposure to SARS-CoV-2 (T1)	7.67 (1.27, 46.32); p = 0.02*
ETEA-PT	PIL (T1)	0.72 (0.64, 0.80); p < 0.001***
	Personal and family/friends’ exposure to SARS-CoV-2 (T1)	5.76 (2.14, 15.53); p = 0.001**
Psychopathology	PIL (T1)	0.30 (0.18, 0.49); p < 0.001***
	Personal and family/friends’ exposure to SARS-CoV-2 (T1)	328.84 (8.87, 12,184.10); p = 0.002**

OR, odds ratio; PIL, purpose in life; BAI, Beck Anxiety Inventory; BDI-II, Beck Depression Inventory; ETEA-PT, Acute/Post-Traumatic Stress Disorder Scale; DAST-10, Drug Abuse Screening Test-10; AUDIT, Alcohol Use Disorders Identification Test. ^*p < 0.05, ^**p < 0.01, and ^***p < 0.001.

^aPersonal and family/friends’ exposure to SARS-CoV-2, PMCS, and PIL scores at T1 were introduced as predictor variables.